These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

462 related items for PubMed ID: 16741927

  • 1. Leukemogenic AML1-ETO fusion protein upregulates expression of connexin 43: the role in AML 1-ETO-induced growth arrest in leukemic cells.
    Li X, Xu YB, Wang Q, Lu Y, Zheng Y, Wang YC, Lübbert M, Zhao KW, Chen GQ.
    J Cell Physiol; 2006 Sep; 208(3):594-601. PubMed ID: 16741927
    [Abstract] [Full Text] [Related]

  • 2. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.
    Yan M, Kanbe E, Peterson LF, Boyapati A, Miao Y, Wang Y, Chen IM, Chen Z, Rowley JD, Willman CL, Zhang DE.
    Nat Med; 2006 Aug; 12(8):945-9. PubMed ID: 16892037
    [Abstract] [Full Text] [Related]

  • 3. Inducible expression of AML1-ETO fusion protein endows leukemic cells with susceptibility to extrinsic and intrinsic apoptosis.
    Lu Y, Xu YB, Yuan TT, Song MG, Lübbert M, Fliegauf M, Chen GQ.
    Leukemia; 2006 Jun; 20(6):987-93. PubMed ID: 16598301
    [Abstract] [Full Text] [Related]

  • 4. Leukemogenic AML1-ETO fusion protein increases carcinogen-DNA adduct formation with upregulated expression of cytochrome P450-1A1 gene.
    Xu M, Li D, Lu Y, Chen GQ.
    Exp Hematol; 2007 Aug; 35(8):1249-55. PubMed ID: 17560011
    [Abstract] [Full Text] [Related]

  • 5. The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner.
    Elsässer A, Franzen M, Kohlmann A, Weisser M, Schnittger S, Schoch C, Reddy VA, Burel S, Zhang DE, Ueffing M, Tenen DG, Hiddemann W, Behre G.
    Oncogene; 2003 Aug 28; 22(36):5646-57. PubMed ID: 12944913
    [Abstract] [Full Text] [Related]

  • 6. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F, Pisegna S, Diverio D.
    Haematologica; 1997 Aug 28; 82(3):364-70. PubMed ID: 9234595
    [Abstract] [Full Text] [Related]

  • 7. Williams-Beuren syndrome critical region-5/non-T-cell activation linker: a novel target gene of AML1/ETO.
    Fliegauf M, Stock M, Berg T, Lübbert M.
    Oncogene; 2004 Dec 02; 23(56):9070-81. PubMed ID: 15489901
    [Abstract] [Full Text] [Related]

  • 8. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.
    Pabst T, Mueller BU, Harakawa N, Schoch C, Haferlach T, Behre G, Hiddemann W, Zhang DE, Tenen DG.
    Nat Med; 2001 Apr 02; 7(4):444-51. PubMed ID: 11283671
    [Abstract] [Full Text] [Related]

  • 9. AML1/ETO-induced survivin expression inhibits transcriptional regulation of myeloid differentiation.
    Balkhi MY, Christopeit M, Chen Y, Geletu M, Behre G.
    Exp Hematol; 2008 Nov 02; 36(11):1449-60. PubMed ID: 18687517
    [Abstract] [Full Text] [Related]

  • 10. The 8;21 translocation in leukemogenesis.
    Peterson LF, Zhang DE.
    Oncogene; 2004 May 24; 23(24):4255-62. PubMed ID: 15156181
    [Abstract] [Full Text] [Related]

  • 11. AML1-ETO positive AML: first report from India.
    Dutta P, Hasan SK, Sazawal S, Kumar B, Bhattacharyya J, Jain M, Tyagi S, Kumar R, Pati HP, Saxena R.
    Indian J Pathol Microbiol; 2007 Jul 24; 50(3):652-4. PubMed ID: 17883173
    [Abstract] [Full Text] [Related]

  • 12. Discrimination of target by siRNA: designing of AML1-MTG8 fusion mRNA-specific siRNA sequences.
    Kasashima K, Sakota E, Kozu T.
    Biochimie; 2004 Jul 24; 86(9-10):713-21. PubMed ID: 15556282
    [Abstract] [Full Text] [Related]

  • 13. Disruption of the NHR4 domain structure in AML1-ETO abrogates SON binding and promotes leukemogenesis.
    Ahn EY, Yan M, Malakhova OA, Lo MC, Boyapati A, Ommen HB, Hines R, Hokland P, Zhang DE.
    Proc Natl Acad Sci U S A; 2008 Nov 04; 105(44):17103-8. PubMed ID: 18952841
    [Abstract] [Full Text] [Related]

  • 14. Multi-sites cleavage of leukemogenic AML1-ETO fusion protein by caspase-3 and its contribution to increased apoptotic sensitivity.
    Lu Y, Peng ZG, Yuan TT, Yin QQ, Xia L, Chen GQ.
    Leukemia; 2008 Feb 04; 22(2):378-86. PubMed ID: 17989718
    [Abstract] [Full Text] [Related]

  • 15. The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1.
    Frank RC, Sun X, Berguido FJ, Jakubowiak A, Nimer SD.
    Oncogene; 1999 Mar 04; 18(9):1701-10. PubMed ID: 10208431
    [Abstract] [Full Text] [Related]

  • 16. Molecular cytogenetic findings in a three-way novel variant of t(1;8;21)(p35;q22;q22): a unique relocation of the AML1/ETO fusion gene 1p35 in AML-M2.
    Ahmad F, Kokate P, Chheda P, Dalvi R, Das BR, Mandava S.
    Cancer Genet Cytogenet; 2008 Jan 15; 180(2):153-7. PubMed ID: 18206543
    [Abstract] [Full Text] [Related]

  • 17. The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia.
    Linggi B, Müller-Tidow C, van de Locht L, Hu M, Nip J, Serve H, Berdel WE, van der Reijden B, Quelle DE, Rowley JD, Cleveland J, Jansen JH, Pandolfi PP, Hiebert SW.
    Nat Med; 2002 Jul 15; 8(7):743-50. PubMed ID: 12091906
    [Abstract] [Full Text] [Related]

  • 18. Pontin is a critical regulator for AML1-ETO-induced leukemia.
    Breig O, Bras S, Martinez Soria N, Osman D, Heidenreich O, Haenlin M, Waltzer L.
    Leukemia; 2014 Jun 15; 28(6):1271-9. PubMed ID: 24342949
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. AML1-ETO triggers epigenetic activation of early growth response gene l, inducing apoptosis in t(8;21) acute myeloid leukemia.
    Fu L, Huang W, Jing Y, Jiang M, Zhao Y, Shi J, Huang S, Xue X, Zhang Q, Tang J, Dou L, Wang L, Nervi C, Li Y, Yu L.
    FEBS J; 2014 Feb 15; 281(4):1123-31. PubMed ID: 24314118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.